Compounds > erlotinib hydrochloride
Page last updated: 2024-09-05

erlotinib hydrochloride and Li-Fraumeni Syndrome

erlotinib hydrochloride has been researched along with Li-Fraumeni Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Calcasola, M; Cane, P; Izatt, L; Michalarea, V; Spicer, J; Tobal, K1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Li-Fraumeni Syndrome

ArticleYear
EGFR-mutated lung cancer in Li-Fraumeni syndrome.
    Lung cancer (Amsterdam, Netherlands), 2014, Volume: 85, Issue:3

    Topics: Adult; Breast Neoplasms; DNA Mutational Analysis; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Li-Fraumeni Syndrome; Lung Neoplasms; Middle Aged; Mutation; Quinazolines; Tomography, X-Ray Computed; Treatment Outcome; Tumor Suppressor Protein p53; Young Adult

2014